Highlights from the 2025 ISPAD conference
Bonjour from Montreal, Canada, where the latest and greatest in type 1 diabetes (T1D) research was presented at the International Society for Pediatric and Adolescent Diabetes (ISPAD) 51st Annual Conference. ISPAD is a yearly highlight of the T1D conference calendar, and this year was no exception. Scientists, clinicians, researchers, industry members, people with diabetes, and […]
Ten years of impact: A closer look at Breakthrough T1D’s training awards
To drive our mission forward, Breakthrough T1D financially supports type 1 diabetes (T1D) research through training awards and grants to academic scientists or clinicians, investments in promising companies, conference support, and more. Here, we take a deeper dive specifically into our training awards offered to early-stage researchers to understand the impact and outcomes that these […]
A new Breakthrough T1D publication is paving the way for beta cell replacement therapies
Breakthrough T1D’s newest publication outlines a roadmap for beta cell replacement therapies for type 1 diabetes.
Breakthrough T1D helps organize an event at the European Parliament about unmet needs for T1D and accelerating cures
This meeting focused on the role of the EU in addressing the needs of the T1D community and accelerating T1D breakthroughs.
Medical Affairs team kicks off international islet cell therapy workshops at Breakthrough T1D HQ
Breakthrough T1D's Medical Affairs team hosted experts in islet transplantation to discuss a clinical roadmap for manufactured cell therapies.
New Breakthrough T1D publications highlight unmet needs and demographics of the T1D population
Breakthrough T1D recently published two peer-reviewed journal articles. One detailed burdensome unmet needs in the T1D community and identified key steps we can take to meet these needs. The other used real-world data to better understand American T1D demographics and predict changes in the next decade.
Riding coast to coast for cures
Matt Varey, a key volunteer with Breakthrough T1D, will embark on a two-month-long, 7,500 km cycling journey across Canada to fundraise for the type 1 diabetes community.
From unexpected diagnosis to DIAGNODE-3 participant
Katie Howell was diagnosed with type 1 diabetes last year at age 25. Now, she's the first DIAGNODE-3 trial participant in NYC.
ATTD 2025: Closing the loop to cures
At ATTD 2025, Breakthrough T1D led sessions showcasing advancements in T1D cell therapies, early detection, and technology to improve lives.
From Breakthrough T1D trainee to Principal Investigator: Kelsey Voss, Ph.D., is calling the shots
Kelsey Voss, Ph.D., received Breakthrough T1D's Advanced Postdoctoral Fellowship Award, which helped start her lab at UVA studying T cells in type 1 diabetes.
